Why Is Ericsson Down By 9%? 22 Stocks Moving In Thursday's Pre-Market Session

Gainers

• Allena Pharmaceuticals, Inc. (NASDAQ: ALNA) rose 22.1% to $0.2050 in pre-market trading. Allena Pharmaceuticals disclosed a new meeting date and new record date for special meeting to approve reverse stock split.
• Aditxt, Inc. (NASDAQ: ADTX) rose 20.9% to $0.2085 in pre-market trading after declining over 11% on Wednesday. Aditxt’s Adimune therapeutic program recently completed a toxicology study indicating a favorable safety profile of ADI-100.
• Theravance Biopharma, Inc. (NASDAQ: TBPH) rose 19.4% to $10.30 in pre-market trading. Theravance Biopharma agreed to sell all of its units in Theravance Respiratory Company, LLC, representing 85% economic interest in the sales-based royalty rights on worldwide net sales of GSK’s TRELEGY ELLIPTA to Royalty Pharma for over $1.5 billion.
• Medicenna Therapeutics Corp. (NASDAQ: MDNA) rose 9.4% to $1.51 in pre-market trading after jumping around 16% on Wednesday.
• Taoping Inc. (NASDAQ: TAOP) rose 9.9% to $1.11 in pre-market trading.
• Scopus BioPharma Inc. (NASDAQ: SCPS) rose 9.6% to $0.4646 in pre-market trading.
• Predictive Oncology Inc. (NASDAQ: POAI) rose 8.3% to $0.45 in pre-market trading.
• Endo International plc (NASDAQ: ENDP) rose 7.8% to $0.4465 in pre-market trading. Endo International is considering bankruptcy filing to restructure its more than $8 billion of debt and several outstanding lawsuits without a deal with opioid plaintiffs, the Wall Street Journal reported, citing people familiar with the matter.
• Exela Technologies, Inc. (NASDAQ: XELA) rose 7.8% to $0.1029 in pre-market trading. Exela Technologies confirmed the receipt of acquisition proposal.
• TransGlobe Energy Corporation (NASDAQ: TGA) rose 7.2% to $3.41 in pre-market trading. VAALCO announced plans to acquire TransGlobe in an all-stock transaction.

Don’t forget to check out our premarket coverage here .

Losers

• ContraFect Corporation (NASDAQ: CFRX) fell 76.1% to $0.68 in pre-market trading after the company announced Wednesday an independent DSMB recommended that the Exebacase Phase 3 Disrupt Study be stopped for futility following interim analysis.
• Qurate Retail, Inc. (NASDAQ: QRTEB) shares fell 17.3% to $4.30 in pre-market trading after jumping 71% on Wednesday. Qurate Retail is scheduled to host a conference call to discuss Q2 results on Friday, August 5th.
• VAALCO Energy, Inc. (NYSE: EGY) fell 14.5% to $5.32 in pre-market trading. VAALCO announced plans to acquire TransGlobe in an all-stock transaction.
• Versus Systems Inc. (NASDAQ: VS) fell 13% to $0.47 in pre-market trading after reporting a $2.16 million registered direct offering.
• Nano Labs Ltd (NASDAQ: NA) fell 12.3% to $7.71 in pre-market trading amid post-IPO volatility after the stock opened for trade on Tuesday.
• Fast Radius, Inc. (NASDAQ: FSRD) fell 10.8% to $0.5601 in pre-market trading after declining 8% on Wednesday.
• Sonim Technologies, Inc. (NASDAQ: SONM) fell 9.9% to $0.5760 in pre-market trading after jumping 16% on Wednesday.
• COMSovereign Holding Corp. (NASDAQ: COMS) fell 9.1% to $0.1455 in pre-market trading after declining more than 12% on Wednesday.
• Telefonaktiebolaget LM Ericsson (NASDAQ: ERIC) fell 9% to $6.82 in pre-market trading after the company reported downbeat core earnings for its second quarter.
• XORTX Therapeutics Inc. (NASDAQ: XRTX) fell 8.8% to $1.65 in pre-market trading. XORTX shares jumped 47% on Wednesday after the company announced topline results from Part 1 of the 3 part Pharmacokinetics Bridging Study showed a substantial increase in oral bioavailability of two versions of its proprietary oxypurinol formulation.
• TDH Holdings, Inc. (NASDAQ: PETZ) shares fell 8.2% to $2.69 in pre-market trading. TDH Holdings shares jumped 42% on Wednesday after the company announced the withdrawal of its registration statement. The company will not proceed with its proposed offering.
• Powerbridge Technologies Co., Ltd. (NASDAQ: PBTS) shares fell 8% to $0.7635 in pre-market trading after climbing 24% on Wednesday.